LAZARI CAPITAL MANAGEMENT, INC.

Position in GSK — GSK plc

CIK 1986389 WOODLAND HILLS, CA

Position in GSK

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$641,620

-$83,797 QoQ

Shares Held

12,240

-6.9% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.22%

of 13F equity value

Holder Rank

#428

of 1,033 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

LAZARI CAPITAL MANAGEMENT, INC. holds $11,558,274 across 8 Drug Manufacturers - General names. GSK ranks #8 (5.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	16,094	$4,049,894
2	JNJ	Johnson & Johnson	6,179	$1,569,280
3	PFE	Pfizer Inc	64,489	$1,552,895
4	LLY	ELI LILLY & Co	1,119	$1,342,162
5	BMY	Bristol Myers Squibb Co	17,208	$991,524
6	MRK	Merck & Co., Inc.	5,710	$733,735
7	AMGN	Amgen Inc	1,870	$677,164
8	GSK	GSK plc This page	12,240	$641,620

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$641,620	12,240	-6.9%	Shares	Sole	2026-07-23
2026-03-31	$725,417	13,144	+1.1%	Shares	Sole	2026-04-24
2025-12-31	$637,569	13,001	-6.5%	Shares	Sole	2026-01-29
2025-09-30	$599,967	13,901	-22.9%	Shares	Sole	2025-10-28
2025-06-30	$692,006	18,021	-0.5%	Shares	Sole	2025-07-17
2025-03-31	$701,581	18,110	-6.7%	Shares	Sole	2025-04-23
2024-12-31	$656,513	19,412	-0.7%	Shares	Sole	2025-01-24
2024-09-30	$799,040	19,546	-2.1%	Shares	Sole	2024-10-22
2024-06-30	$768,845	19,970	+2.5%	Shares	Sole	2024-09-09
2024-03-31	$835,279	19,484	-3.6%	Shares	Sole	2024-06-24
2023-12-31	$748,760	20,204	-36.5%	Shares	Sole	2024-02-27
2023-09-30	$1,152,895	31,804	-0.2%	Shares	Sole	2023-11-07
2023-06-30	$1,135,632	31,864	—	Shares	Sole	2023-07-20
No filing history on record for this holder in this stock.